Get the latest Science News and Discoveries

Study opens new avenue for immunotherapy drug development - EurekAlert

<p>In a new study published today in <em>Nature Biomedical Engineering</em>, researchers at The University of Texas MD Anderson Cancer Center have designed a new method for developing immunotherapy drugs using engineered peptides to elicit a natural immune response inside the body.</p>

None

Get the Android app